Circulating cytokines and granulocyte-derived enzymes during complex heart surgery - A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits

被引:18
作者
Borowiec, JW
Hagman, L
Totterman, TH
Pekna, M
Venge, P
Thelin, S
机构
[1] UNIV UPPSALA HOSP,DEPT CLIN IMMUNOL & TRANSFUS MED,S-75185 UPPSALA,SWEDEN
[2] UNIV UPPSALA HOSP,DEPT CLIN CHEM,S-75185 UPPSALA,SWEDEN
来源
SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 1995年 / 29卷 / 04期
关键词
cardiopulmonary bypass; inflammatory response; cytokines; granulocyte-derived enzymes; heparin-coating;
D O I
10.3109/14017439509107225
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Blood contact with artificial surfaces during cardiopulmonary bypass (CPB) triggers a systemic inflammatory response in which complement, granulocytes and cytokines play a major role. Heparin-coated CPB circuits were recently shown to reduce complement and granulocyte activation in such circumstances. The present study comprised 20 complex heart operations, 10 with heparin-coated circuits (group HC) and 10 controls (group C), with evaluation of changes in terminal complement complex, the granulocyte enzymes myeloperoxidase and lactoferrin, and the cytokines interleukin-6 (IL-6) and interleukin-8 (IL-8). Standard heparin dose and uncoated cardiotomy reservoir were used in all cases. In both groups the levels of enzymes and terminal complement complex rose significantly, beginning at conclusion of CPB, above base values, without significant intergroup differences. IL-6 and IL-8 also increased significantly, but tended to be lower in the HC group, starting at CPB end and continuing until 20 hours postoperatively: for IL-6 the difference was significant at CPB end (83 +/- 18 vs 197 +/- 39 mu g/l, p = 0.21). Significantly increased inflammatory response was thus found during complex heart operations even with use of heparin-coated CPB sets. The heparin-coating of circuits seems to diminish cytokine production.
引用
收藏
页码:167 / 174
页数:8
相关论文
共 23 条
  • [1] COAGULATION, FIBRINOLYSIS AND BLEEDING AFTER OPEN-HEART-SURGERY
    BAGGE, L
    LILIENBERG, G
    NYSTROM, SO
    TYDEN, H
    [J]. SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1986, 20 (02): : 151 - 160
  • [2] Baggiolini M, 1992, Cytokines, V4, P1
  • [3] DECREASED BLOOD-LOSS AFTER CARDIOPULMONARY BYPASS USING HEPARIN-COATED CIRCUIT AND 50-PERCENT REDUCTION OF HEPARIN DOSE
    BOROWIEC, J
    THELIN, S
    BAGGE, L
    HULTMAN, J
    HANSSON, HE
    [J]. SCANDINAVIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1992, 26 (03): : 177 - 185
  • [4] BOROWIEC J, 1992, J THORAC CARDIOV SUR, V104, P642
  • [5] HEPARIN COATING REDUCES BLOOD-CELL ADHESION TO ARTERIAL FILTERS DURING CORONARY-BYPASS - A CLINICAL-STUDY
    BOROWIEC, JW
    BYLOCK, A
    VANDERLINDEN, J
    THELIN, S
    [J]. ANNALS OF THORACIC SURGERY, 1993, 55 (06) : 1540 - 1545
  • [6] CYTOKINE RESPONSES TO CARDIOPULMONARY BYPASS WITH MEMBRANE AND BUBBLE OXYGENATION
    BUTLER, J
    CHONG, GL
    BAIGRIE, RJ
    PILLAI, R
    WESTABY, S
    ROCKER, GM
    [J]. ANNALS OF THORACIC SURGERY, 1992, 53 (05) : 833 - 838
  • [7] COMPLEMENT ACTIVATION DURING CARDIOPULMONARY BYPASS - EVIDENCE FOR GENERATION OF C3A AND C5A ANAPHYLATOXINS
    CHENOWETH, DE
    COOPER, SW
    HUGLI, TE
    STEWART, RW
    BLACKSTONE, EH
    KIRKLIN, JW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (09) : 497 - 503
  • [8] Courtney JM, 1992, CARDIOVASCULAR BIOMA, P37
  • [9] DURUM SK, 1989, FUNDAMENTAL IMMUNOLO, P639
  • [10] CHANGES IN NEUTROPHIL CD11B/CD18 AND L-SELECTIN EXPRESSION AND RELEASE OF INTERLEUKIN-8 AND ELASTASE IN PEDIATRIC CARDIOPULMONARY BYPASS
    FINN, A
    MOAT, N
    REBUCK, N
    KLEIN, N
    STROBEL, S
    ELLIOTT, M
    [J]. AGENTS AND ACTIONS, 1993, 38 : C44 - C46